Agenus Inc (AGEN)
10.96
+2.66
(+32.05%)
USD |
NASDAQ |
Apr 26, 13:47
Agenus Debt to Equity Ratio: -0.0805 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0805 |
| September 30, 2023 | -0.1015 |
| June 30, 2023 | -0.1427 |
| March 31, 2023 | -0.2332 |
| December 31, 2022 | -0.2147 |
| September 30, 2022 | -0.6602 |
| June 30, 2022 | 4.010 |
| March 31, 2022 | 0.9022 |
| December 31, 2021 | 0.3935 |
| September 30, 2021 | 0.3184 |
| June 30, 2021 | -0.0801 |
| March 31, 2021 | -0.1074 |
| December 31, 2020 | -0.0968 |
| September 30, 2020 | -0.1009 |
| June 30, 2020 | -0.0931 |
| March 31, 2020 | -0.0675 |
| December 31, 2019 | -0.0622 |
| September 30, 2019 | -0.0693 |
| June 30, 2019 | -0.087 |
| March 31, 2019 | -0.1164 |
| December 31, 2018 | -0.0775 |
| September 30, 2018 | -0.1012 |
| June 30, 2018 | -0.1158 |
| March 31, 2018 | -0.1139 |
| December 31, 2017 | -2.150 |
| Date | Value |
|---|---|
| September 30, 2017 | -2.776 |
| June 30, 2017 | -7.933 |
| March 31, 2017 | 15.08 |
| December 31, 2016 | -3.340 |
| September 30, 2016 | -6.008 |
| June 30, 2016 | 7.245 |
| March 31, 2016 | 2.661 |
| December 31, 2015 | 1.618 |
| September 30, 2015 | 1.438 |
| June 30, 2015 | 0.1311 |
| March 31, 2015 | 0.2487 |
| December 31, 2014 | 0.2618 |
| September 30, 2014 | 0.1374 |
| June 30, 2014 | 0.1289 |
| March 31, 2014 | 0.1479 |
| December 31, 2013 | -1.979 |
| September 30, 2013 | -3.242 |
| June 30, 2013 | -0.5348 |
| March 31, 2013 | -1.286 |
| December 31, 2012 | -0.0103 |
| September 30, 2012 | -1.895 |
| June 30, 2012 | -2.078 |
| March 31, 2012 | -2.054 |
| December 31, 2011 | -1.247 |
| September 30, 2011 | -1.936 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.6602
Minimum
Sep 2022
4.010
Maximum
Jun 2022
0.1804
Average
-0.087
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| Protalix BioTherapeutics Inc | 0.6033 |
| InfuSystems Holdings Inc | 0.5564 |
| PAVmed Inc | -0.8211 |
| Allogene Therapeutics Inc | 0.00 |
| Pfizer Inc | 0.7959 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 313.91M |
| Total Liabilities (Quarterly) | 462.30M |
| Shareholders Equity (Quarterly) | -160.33M |
| Current Ratio | 0.4393 |
| Net Debt Paydown Yield | 0.03% |